Journal of Biomolecular Screening

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosse, R.
Right arrow Articles by Menard, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bosse, R.
Right arrow Articles by Menard, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Biomolecular Screening, Vol. 3, No. 4, 285-292 (1998)
DOI: 10.1177/108705719800300407

Development of Nonseparation Binding and Functional Assays for G Protein-Coupled Receptors for High Throughput Screening: Pharmacological Characterization of the Immobilized CCR5 Receptor on FlashPlate(r)

Roger Bosse

BioSignal Inc. 1744 William, Montreal, Quebec, Canada H3J 1R4

Russell Garlick

NEN Life Science, Boston, MA 02118-2512

Beverly Brown

NEN Life Science, Boston, MA 02118-2512

Luc Menard

BioSignal Inc. 1744 William, Montreal, Quebec, Canada H3J 1R4

G protein-coupled receptors (GPCRs) represent a very important class of drug targets. The development of microformatted nonseparation assays constitute a key step in the process of assay development for high throughput drug screening (HTS). We have developed a microformatted nonseparation assay for membrane preparations containing the CCR5 GPCR using FlashPlate® microplates (Packard Instrument Company, Meriden, CT). The pharmacodynamic (radioligand-binding) and functional (agonist-stimulated [35S]GTP{gamma}S binding) properties of this receptor observed in FlashPlate-based assays were compared with standard filtration assays. Saturation binding experiments performed using either assay platform revealed identical Kd for [125I]-MIP-1 ß (0.7 nM). Comparable signal-to-noise ratios (SNR), similar affinities (Ki), and identical order of potency (RANTES {cong} MIP-1ß > MIP-1{alpha}) were observed following competition binding assays in both platforms. In functional assays, the order of potency for different agonists were similar in both platforms with RANTES {cong} MIP-1ß ≥ MIP-1{alpha}, which correspond to the relative affinities determined for the three ligands in competition binding experiments. Because similar pharmacologic properties were obtained in both FlashPlate microplates and standard filtration platforms, we conclude that FlashPlate microplates could provide a valuable nonseparation platform for primary and secondary HTS for this and possibly other GPCRs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Biomol ScreenHome page
K. Moore and S. Rees
Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel?
J Biomol Screen, April 1, 2001; 6(2): 69 - 74.
[PDF]

Home page
 J Biomol ScreenHome page
A. A. Scheel, B. Funsch, M. Busch, G. Gradl, J. Pschorr, and M. J. Lohse
Receptor-Ligand Interactions Studied with Homogeneous Fluorescence-Based Assays Suitable for Miniaturized Screening
J Biomol Screen, February 1, 2001; 6(1): 11 - 18.
[Abstract] [PDF]